| Accession number |
System name |
1H shifts |
13C shifts |
15N shifts |
31P shifts |
Protein |
DNA |
RNA |
| 19222 |
Four dodecamers that together cover 39 bp of the 5' half of the strong nucleosome positioning sequence 601 |
0 |
0 |
0 |
88 |
|
X |
|
| 4172 |
Rev-erb beta response element |
268 |
0 |
0 |
28 |
|
X |
|
| 5134 |
dAAUAA DNA Bulge: 5'-D(*GP*CP*AP*TP*CP*GP*AP*AP*UP*AP*AP*GP*CP*TP*AP*CP*G)-3' |
248 |
0 |
0 |
27 |
|
X |
|
| 4555 |
SRY-14mer duplex |
243 |
0 |
0 |
26 |
|
X |
|
| 5135 |
dAATAA DNA Bulge: 5'-D(*GP*CP*AP*TP*CP*GP*AP*AP*TP*AP*AP*GP*CP*TP*AP*CP*G)-3' |
241 |
0 |
0 |
26 |
|
X |
|
| 17129 |
25-mer DNA oligomer |
254 |
139 |
0 |
25 |
|
X |
|
| 15527 |
Mbp1_14 |
227 |
116 |
0 |
25 |
|
X |
|
| 18279 |
human CEB25 minisatellite G-quadruplex |
233 |
56 |
0 |
25 |
|
X |
|
| 19387 |
intramolecular (3+1) human telomeric G-quadruplex bound to a telomestatin derivative |
240 |
0 |
0 |
23 |
|
X |
|
| 5671 |
5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3' |
0 |
0 |
0 |
22 |
|
X |
|
| 15360 |
DNA 12mer |
266 |
0 |
0 |
22 |
|
X |
|
| 4416 |
Cis-syn thymine cyclobutane dimer |
193 |
0 |
0 |
22 |
|
X |
|
| 4415 |
DNA dodecamer duplex |
193 |
0 |
0 |
22 |
|
X |
|
| 4692 |
TELOMERE FRAGMENT |
239 |
0 |
0 |
21 |
|
X |
|
| 16225 |
5'-D(*DGP*DTP*DGP*DCP*DGP*(TG)P*DGP*DTP*DTP*DTP*DGP*DT)-3' |
231 |
0 |
0 |
20 |
|
X |
|
| 18040 |
DNA_1 |
202 |
0 |
0 |
20 |
|
X |
|
| 17887 |
alpha anomeric lesion |
177 |
56 |
0 |
18 |
|
X |
|
| 4141 |
vnd/NK-2 homeodomain DNA complex |
840 |
291 |
100 |
18 |
X |
X |
|
| 4646 |
DNA |
136 |
0 |
0 |
17 |
|
X |
|
| 17535 |
DNA/RNA hybrid |
130 |
36 |
0 |
16 |
|
X |
X |
| 4547 |
DNA/RNA |
168 |
0 |
0 |
16 |
|
X |
X |
| 6430 |
HIV-1 integrase inhibitor, 93del |
148 |
0 |
0 |
15 |
|
X |
|
| 6009 |
Thrombin-binding DNA aptamer |
150 |
0 |
0 |
14 |
|
X |
|
| 4556 |
SRY-8mer duplex |
137 |
0 |
0 |
14 |
|
X |
|
| 5245 |
5'-D(*TP*GP*TP*TP*TP*GP*GP*C)-3' |
109 |
0 |
0 |
13 |
|
X |
|
| 6273 |
GTTCACAGAAC DNA hairpin |
101 |
0 |
0 |
10 |
|
X |
|
| 4243 |
DNA (5'-D(TCCCGTTTCCA)-3') |
84 |
0 |
0 |
10 |
|
X |
|
| 4235 |
DNA decamer |
82 |
0 |
0 |
9 |
|
X |
|
| 4244 |
alphaT decamer duplex |
94 |
0 |
0 |
9 |
|
X |
|
| 18050 |
DNA_1 |
179 |
0 |
0 |
9 |
|
X |
|
| 5681 |
CYCLIC OLIGONUCLEOTIDE D(CGCTCATT) |
91 |
0 |
0 |
8 |
|
X |
|
| 16289 |
d(GCTATAGC)2 |
48 |
0 |
0 |
7 |
|
X |
|
| 16286 |
d(CGAGCTCG)2 |
46 |
0 |
0 |
7 |
|
X |
|
| 4753 |
D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND ZINC |
135 |
96 |
0 |
7 |
|
X |
|
| 4746 |
D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT |
127 |
80 |
0 |
7 |
|
X |
|
| 16282 |
d(AGAGCTCT)2 |
48 |
0 |
0 |
7 |
|
X |
|
| 15898 |
DNA GAAA tetraloop |
72 |
42 |
0 |
7 |
|
X |
|
| 4362 |
chromomycin-DNA complex |
160 |
96 |
0 |
7 |
|
X |
|
| 4361 |
chromomycin-DNA complex |
152 |
80 |
0 |
7 |
|
X |
|
| 5282 |
5'-D(*GP*CP*GP*AP*AP*GP*C)-3' |
68 |
35 |
9 |
6 |
|
X |
|
| 15033 |
cyclic octamer |
43 |
20 |
0 |
4 |
|
X |
|
| 15223 |
AB_G_alpha |
228 |
0 |
0 |
0 |
|
X |
|
| 16290 |
1:1 complex |
50 |
0 |
0 |
0 |
|
X |
|
| 16834 |
5'-D(*DGP*DCP*DGP*DAP*DGP*(6MT)P*DTP*DCP*DTP*DGP*DCP*DG)-3' |
137 |
0 |
0 |
0 |
|
X |
|
| 17422 |
Cidofovir DNA duplex |
162 |
4 |
0 |
0 |
|
X |
|
| 15227 |
duplex DNA containing an abasic site with opposite T (alpha anomer) |
225 |
0 |
0 |
0 |
|
X |
|
| 16055 |
5'-D(P*TP*CP*GP*TP*TP*GP*CP*T)-3' |
79 |
0 |
0 |
0 |
|
X |
|
| 16356 |
5'-D(*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*(INO)P*GP*GP*TP*TP*AP*GP*GP*GP*T)-3' |
210 |
0 |
0 |
0 |
|
X |
|
| 16226 |
5'-D(*DGP*DTP*DGP*DCP*DGP*(TG)P*DGP*DTP*DTP*DTP*DGP*DT)-3' |
230 |
0 |
0 |
0 |
|
X |
|
| 17655 |
Human Telomeric DNA |
189 |
0 |
0 |
0 |
|
X |
|
| 11437 |
Propylene-DNA |
213 |
0 |
0 |
0 |
|
X |
|
| 15026 |
Nar1IQ3 Duplex |
204 |
0 |
0 |
0 |
|
X |
|
| 16292 |
2:1 complex |
58 |
0 |
0 |
0 |
|
X |
|
| 15083 |
SIGMA-54 RPON DOMAIN-DNA COMPLEX |
613 |
208 |
61 |
0 |
X |
X |
|
| 15239 |
Ab_C_beta |
204 |
0 |
0 |
0 |
|
X |
|
| 17786 |
(5'S)-8,5'-cyclo-2'-deoxyguanosine |
167 |
0 |
0 |
0 |
|
X |
|
| 17787 |
(5'S)-8,5'-cyclo-2'-deoxyguanosine |
164 |
0 |
0 |
0 |
|
X |
|
| 17789 |
(5'S)-8,5'-cyclo-2'-deoxyadenosine |
171 |
0 |
0 |
0 |
|
X |
|
| 17790 |
(6S,8R,11S) gamma-hydroxy-1,N2-propano-deoxyguanosine adduct |
152 |
0 |
0 |
0 |
|
X |
|
| 17562 |
N2-dG:N2-dG interstrand cross-link induced by trans-4-hydroxynonenal |
150 |
0 |
0 |
0 |
|
X |
|
| 17814 |
DNA Containing an Aristolactam II-dA Lesion |
82 |
0 |
0 |
0 |
|
X |
|
| 17859 |
DNA duplex Containing an Unnatural, Hydrophobic Base Pair |
155 |
0 |
0 |
0 |
|
X |
|
| 17885 |
DNA_dodecamer |
73 |
0 |
0 |
0 |
|
X |
|
| 16936 |
MBD2 bound to a methylated DNA |
530 |
307 |
70 |
0 |
X |
X |
|
| 17729 |
C-Terminal domain of Ler |
599 |
151 |
59 |
0 |
X |
X |
|
| 15027 |
Nar1 Duplex |
203 |
0 |
0 |
0 |
|
X |
|
| 16288 |
1:2 complex |
49 |
0 |
0 |
0 |
|
X |
|
| 16054 |
5'-D(TP*CP*GP*TP*TP*GP*CP*T)-3' |
83 |
0 |
0 |
0 |
|
X |
|
| 18209 |
DNA_molecule_G3ATG3ACACAG4ACG3 |
153 |
0 |
0 |
0 |
|
X |
|
| 16138 |
34-MER, SILVER ION |
332 |
0 |
0 |
0 |
|
X |
|
| 16212 |
5'-D(TP*CP*GP*TP*TP*GP*CP*T)-3' |
81 |
0 |
0 |
0 |
|
X |
|
| 17791 |
(6S,8R,11S) gamma-hydroxy-1,N2-propano-deoxyguanosine adduct |
143 |
0 |
0 |
0 |
|
X |
|
| 18452 |
Synthetic cyclic oligonucleotide |
116 |
0 |
0 |
0 |
X |
X |
|
| 18453 |
11_mer_oligonucleotide-B |
150 |
0 |
0 |
0 |
|
X |
|
| 18454 |
11_mer_oligonucleotide-B |
150 |
0 |
0 |
0 |
|
X |
|
| 16280 |
d(GAGCTC)2 |
35 |
0 |
0 |
0 |
|
X |
|
| 17980 |
G-quadruplexes |
159 |
0 |
0 |
0 |
|
X |
|
| 18625 |
Self-Complementary 10 mer DNA Oligonucleotide 5'-GGATATATCC-3' |
200 |
0 |
0 |
0 |
|
X |
|
| 17732 |
Complex of the C-terminal WRKY domain of AtWRKY4 and a W-box DNA |
599 |
70 |
80 |
0 |
X |
X |
|
| 18638 |
11_mer_oligonucleotide-B |
142 |
0 |
0 |
0 |
|
X |
|
| 18639 |
Duplex DNA Containing a b-Carba-Fapy-dG Lesion |
150 |
0 |
0 |
0 |
|
X |
|
| 18640 |
Duplex DNA Containing a b-Carba-Fapy-dG Lesion |
150 |
0 |
0 |
0 |
|
X |
|
| 18690 |
MOMERIC PIL-E G-QUADRUPLEX DNA |
188 |
0 |
0 |
0 |
|
X |
|
| 18699 |
DIMERIC PIL-E G-QUADRUPLEX DNA |
134 |
0 |
0 |
0 |
|
X |
|
| 18724 |
G-quadruplex_DNA |
183 |
0 |
0 |
0 |
|
X |
|
| 18762 |
N2-guanine DNA adduct derived from the potent tumorigen dibenzo[a,l]pyrene |
154 |
0 |
0 |
0 |
|
X |
|
| 18835 |
dodecamer duplex |
109 |
0 |
0 |
0 |
|
X |
|
| 18862 |
Parallel human telomeric quadruplex containing 2'F-ANA substitutions |
111 |
0 |
0 |
0 |
|
X |
|
| 18907 |
Duplex DNA |
225 |
0 |
0 |
0 |
|
X |
|
| 19017 |
Bulges in G-quadruplexes |
183 |
0 |
0 |
0 |
|
X |
|
| 19035 |
G-rich VEGF aptamer with LNA modifications |
189 |
0 |
0 |
0 |
|
X |
|
| 17379 |
5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3', 2-CARBOXYQUINOXALINE |
209 |
0 |
0 |
0 |
|
X |
|
| 18199 |
DNA_1 |
48 |
0 |
0 |
0 |
|
X |
|
| 17409 |
triazole-linked DNA duplex |
212 |
94 |
0 |
0 |
|
X |
|
| 19278 |
d[GCGCGAAGCATTCGCGGGGAGGTGGGGAAGGG] duplex-quadruplex hybrid |
266 |
0 |
0 |
0 |
|
X |
|
| 18427 |
2'F-ANA and ANA self-complementary duplex |
72 |
0 |
0 |
0 |
|
X |
|
| 18430 |
Duplex DNA Containing (5 S) 5 ,8-Cyclo-2 -Deoxyadenosine |
149 |
0 |
0 |
0 |
|
X |
|
| 19281 |
d[TTGGGTGGGCGCGAAGCATTCGCGGGGTGGGT] duplex-quadruplex hybrid |
260 |
0 |
0 |
0 |
|
X |
|
| 17580 |
Myc G-quadruplex |
161 |
0 |
0 |
0 |
|
X |
|
| 4103 |
14mer DNA duplex containing the operator sequence BS2 |
258 |
188 |
22 |
0 |
|
X |
|
| 4104 |
BS2 operator DNA complexed with the Antennapedia Homeodomain |
257 |
176 |
23 |
0 |
X |
X |
|
| 11438 |
Protein |
211 |
0 |
0 |
0 |
|
X |
|
| 4165 |
Tn916 integrase DNA complex |
603 |
231 |
80 |
0 |
X |
X |
|
| 4170 |
DNA-duplex-6GP |
131 |
0 |
0 |
0 |
|
X |
|
| 17746 |
(5'S)-8,5'-Cyclo-2'-deoxyguanosine in DNA |
160 |
0 |
0 |
0 |
|
X |
|
| 4176 |
DNA dodecamer |
123 |
0 |
0 |
0 |
|
X |
|
| 4187 |
Sigma-K RNA Polymerase Promoter Consensus Sequence |
204 |
0 |
0 |
0 |
|
X |
|
| 15224 |
AB_G_beta |
228 |
0 |
0 |
0 |
|
X |
|
| 4240 |
Duplex DNA (5'-D(GP*GP*TP*CP*AP*CP*GP*AP*G)-3') (DOT)(5'-D(CP*TP*CP*GP*GP*GP*AP*CP*C)-3') |
109 |
0 |
0 |
0 |
|
X |
|
| 15228 |
duplex DNA containing an abasic site with opposite T (beta anomer) |
225 |
0 |
0 |
0 |
|
X |
|
| 15238 |
Ab_C_alpha |
205 |
0 |
0 |
0 |
|
X |
|
| 4247 |
8mer chimeric hybrid RNA/RNA-DNA duplex with tRNA-DNA junction |
145 |
0 |
0 |
0 |
|
X |
X |
| 4248 |
Lymphoid enhancer-binding factor |
733 |
309 |
88 |
0 |
X |
X |
|
| 4258 |
MCB12T |
94 |
0 |
0 |
0 |
|
X |
|
| 15613 |
5'-D(*(DA)P*(DA)P*(DT)P*(DC)P*(DT)P*(DT)P*(DT)P*(DA)P*(DA)P*(DA)P*(DG)P*(DA)P*(DT)P*(DT))-3' |
138 |
0 |
0 |
0 |
|
X |
|
| 15860 |
5'-D(*DTP*DTP*DAP*DAP*DTP*DTP*DTP*(D33)*(D33)*(D33)*DAP*DAP*DAP*DTP*DTP*DAP*DA)-3' |
169 |
0 |
0 |
0 |
|
X |
|
| 4372 |
apt |
117 |
0 |
0 |
0 |
|
X |
|
| 4392 |
DNA minor groove binder |
94 |
0 |
0 |
0 |
|
X |
|
| 4400 |
H-y5 Triple Helix |
247 |
0 |
0 |
0 |
|
X |
|
| 4409 |
DNA (5'-D(*CP*GP*CP*AP*(HYD)TP*+TP*AP*CP*GP*C)- 3') |
163 |
0 |
0 |
0 |
|
X |
|
| 4412 |
DNA (5'-D(*CP*GP*CP*AP*TP*+TP*AP*CP*GP*C)- 3') |
169 |
0 |
0 |
0 |
|
X |
|
| 16222 |
5'-D(*DCP*DTP*DAP*DTP*(FAG)P*DAP*DTP*DTP*DCP*DA)-3' |
220 |
0 |
0 |
0 |
|
X |
|
| 16223 |
5'-D(*DCP*DTP*(FAG)P*DA)-3' |
46 |
0 |
0 |
0 |
|
X |
|
| 4488 |
DNA decamer |
165 |
0 |
0 |
0 |
|
X |
|
| 4536 |
5'-D(*AP*GP*GP*AP*TP*CP*CP*TP*UP*TP*TP*GP*GP*AP*TP*CP*CP*T)-3' |
183 |
0 |
0 |
0 |
|
X |
|
| 4542 |
5'-D(*AP*GP*GP*AP*TP*CP*CP*TP*TP*TP*UP*GP*GP*AP*TP*CP*CP*T)-3' |
206 |
0 |
0 |
0 |
|
X |
|
| 16281 |
1:1 complex |
42 |
0 |
0 |
0 |
|
X |
|
| 4550 |
5'-D(*GP*CP*GP*TP*TP*AP*AP*CP*GP*C)-3' |
83 |
0 |
0 |
0 |
|
X |
|
| 18626 |
Self-Complementary 10 mer DNA Duplex 5'-GGATATATCC-3' in Complex with Netropsin |
198 |
0 |
0 |
0 |
|
X |
|
| 16287 |
2:1 complex |
54 |
0 |
0 |
0 |
|
X |
|
| 4576 |
a3T3 hybrid |
104 |
0 |
0 |
0 |
|
X |
|
| 4609 |
T-tetrad telomere repeats |
59 |
0 |
0 |
0 |
|
X |
|
| 4618 |
DNA |
104 |
0 |
0 |
0 |
|
X |
|
| 16291 |
2:1 complex |
55 |
0 |
0 |
0 |
|
X |
|
| 4647 |
HPRT Gene Mutation Hotspot with a BPDE2(10R) Adduct |
195 |
0 |
0 |
0 |
|
X |
|
| 4687 |
cyclic oligonucleotide d |
80 |
0 |
0 |
0 |
|
X |
|
| 16485 |
THAP RRM1 |
834 |
351 |
84 |
0 |
X |
X |
|
| 4694 |
cyclic oligonucleotide d |
76 |
0 |
0 |
0 |
|
X |
|
| 4733 |
bulge DNA 12/14mer |
203 |
0 |
0 |
0 |
|
X |
|
| 4734 |
High mobility group protein of Drosophila complexed to a bulge DNA |
417 |
46 |
80 |
0 |
X |
X |
|
| 17229 |
ZNF_DNA |
147 |
0 |
0 |
0 |
X |
X |
|
| 4749 |
DNA THREE-WAY JUNCTION |
282 |
0 |
0 |
0 |
|
X |
|
| 17397 |
RET_oncogene |
209 |
0 |
0 |
0 |
|
X |
|
| 4813 |
LAC REPRESSOR HP62/DNA COMPLEX |
513 |
169 |
66 |
0 |
X |
X |
|
| 4835 |
5'-D(*GP*CP*GP*TP*TP*AP*AP*CP*GP*C)-3' |
82 |
0 |
0 |
0 |
|
X |
|
| 17423 |
Control DNA duplex |
157 |
0 |
0 |
0 |
|
X |
|
| 19280 |
d[AGGGTGGGTGCTGGGGCGCGAAGCATTCGCGAGG] duplex-quadruplex hybrid |
263 |
0 |
0 |
0 |
|
X |
|
| 5164 |
5'-D(P*CP*CP*AP*TP*AP*AP*TP*TP*TP*AP*CP*C)-3' duplex |
232 |
0 |
0 |
0 |
|
X |
|
| 5167 |
AT-Rich DNA with the GAA-Hairpin Loop |
252 |
0 |
0 |
0 |
|
X |
|
| 5243 |
5'-D(*CP*AP*CP*TP*AP*CP*TP*CP*TP*TP*TP*GP*TP*AP*GP*TP*G)-3' |
363 |
0 |
0 |
0 |
|
X |
|
| 17708 |
N-myc |
130 |
0 |
0 |
0 |
|
X |
|
| 17709 |
N-myc |
115 |
0 |
0 |
0 |
|
X |
|
| 5345 |
LACTOSE OPERON REPRESSOR/DNA Complex |
1051 |
458 |
138 |
0 |
X |
X |
|
| 5349 |
Extended PBX Homeodomain-DNA complex |
706 |
317 |
89 |
0 |
X |
X |
|
| 5361 |
TELOMERE REPEAT BINDING FACTOR 1/DNA Complex |
599 |
186 |
67 |
0 |
X |
X |
|
| 5363 |
hERR2-DNA complex |
754 |
322 |
98 |
0 |
X |
X |
|
| 5370 |
beta alanine linked polyamide bound to purine tract DNA |
261 |
0 |
0 |
0 |
|
X |
|
| 5385 |
8oxoG:G mismatch |
116 |
0 |
0 |
0 |
|
X |
|
| 5562 |
CCGCGG |
49 |
0 |
0 |
0 |
|
X |
|
| 5634 |
SS1 |
92 |
75 |
0 |
0 |
|
X |
|
| 5635 |
SS2 |
91 |
74 |
0 |
0 |
|
X |
|
| 5636 |
SS3 |
92 |
75 |
0 |
0 |
|
X |
|
| 5637 |
SS4 |
91 |
74 |
0 |
0 |
|
X |
|
| 5638 |
SS5 |
90 |
73 |
0 |
0 |
|
X |
|
| 5639 |
SS6 |
91 |
74 |
0 |
0 |
|
X |
|
| 5640 |
SS7 |
90 |
73 |
0 |
0 |
|
X |
|
| 5641 |
SS8 |
91 |
74 |
0 |
0 |
|
X |
|
| 5642 |
SS9 |
92 |
75 |
0 |
0 |
|
X |
|
| 5643 |
SS10 |
91 |
74 |
0 |
0 |
|
X |
|
| 5644 |
SS11 |
92 |
75 |
0 |
0 |
|
X |
|
| 5645 |
SS12 |
91 |
74 |
0 |
0 |
|
X |
|
| 5646 |
SS13 |
90 |
73 |
0 |
0 |
|
X |
|
| 5647 |
SS14 |
91 |
74 |
0 |
0 |
|
X |
|
| 5648 |
SS15 |
90 |
73 |
0 |
0 |
|
X |
|
| 5649 |
SS16 |
91 |
74 |
0 |
0 |
|
X |
|
| 18462 |
Kaiso |
1176 |
607 |
164 |
0 |
X |
X |
|
| 18524 |
DNA_OUH |
325 |
135 |
0 |
0 |
|
X |
|
| 5714 |
Synthetic DNA duplex with an AG mismatch |
219 |
0 |
0 |
0 |
|
X |
|
| 5716 |
CK14 DNA 14-MER DUPLEX |
200 |
0 |
0 |
0 |
|
X |
|
| 5717 |
XBY6 DNA 14-MER DUPLEX |
100 |
0 |
0 |
0 |
|
X |
|
| 5718 |
XBY2 DNA 14-MER DUPLEX |
198 |
0 |
0 |
0 |
|
X |
|
| 5730 |
Benzo[a]Pyrene Adducted Adenine in a DNA duplex |
234 |
0 |
0 |
0 |
|
X |
|
| 5737 |
5'-D(*TP*TP*AP*GP*GP*GP*T)-3' |
63 |
0 |
0 |
0 |
|
X |
|
| 5739 |
5'-D(*AP*CP*AP*TP*CP*XP*AP*TP*CP*T)-3' |
203 |
0 |
0 |
0 |
|
X |
|
| 5775 |
5'-R(*AP*AP*AP*GP*GP*AP*GP*GP*A)-3'/5'-D(*CP*CP*UP*CP*CP*UP*U)-3' |
147 |
0 |
0 |
0 |
|
X |
X |
| 5776 |
sPrODN1:RNA |
140 |
0 |
0 |
0 |
|
X |
X |
| 5777 |
PODN:RNA |
157 |
0 |
0 |
0 |
|
X |
X |
| 5781 |
Propynyl_DNA.RNA_hybrid |
175 |
0 |
0 |
0 |
|
X |
X |
| 5791 |
Lactose operon repressor |
497 |
117 |
69 |
0 |
X |
X |
|
| 5927 |
5'-D(*CP*GP*CP*TP*AP*AP*CP*AP*GP*GP*C)-3' |
189 |
0 |
0 |
0 |
|
X |
|
| 5979 |
DNA |
229 |
0 |
0 |
0 |
|
X |
|
| 5993 |
DNA duplex |
114 |
0 |
0 |
0 |
|
X |
|
| 19276 |
d[CGCGAAGCATTCGCG] hairpin |
139 |
0 |
0 |
0 |
|
X |
|
| 19277 |
d[GGTTGGCGCGAAGCATTCGCGGGTTGG] duplex-quadruplex hybrid |
240 |
0 |
0 |
0 |
|
X |
|
| 6274 |
GTACACAGTAC DNA hairpin |
101 |
0 |
0 |
0 |
|
X |
|
| 19279 |
d[GGGAAGGGCGCGAAGCATTCGCGAGGTAGG] duplex-quadruplex hybrid |
245 |
0 |
0 |
0 |
|
X |
|
| 6537 |
5'-d(CTAACAGAATG)-3'/5'-d(CATTCAGTTAG)-3'/Naphthyridine-Azaquinolone1/Naphthyridine-Azaquinolone2 |
208 |
0 |
0 |
0 |
|
X |
|
| 6975 |
Bcl2MidG4Pu23-G15T_G16T |
199 |
0 |
0 |
0 |
|
X |
|
| 7097 |
brinker CG9653-PA/DNA Complex |
536 |
255 |
75 |
0 |
X |
X |
|
| 7105 |
SRY.B in complex with 16-mer DNA |
1377 |
619 |
163 |
0 |
X |
X |
|
| 7392 |
CTC[IQ]GGCGCCATC |
173 |
0 |
0 |
0 |
|
X |
|
